Plexr Plus

Abstract
Plexr Plus is a patented micro-plasma device manufactured by GMV in Italy that generates controlled electric arcs through ionization of atmospheric gases.
Device Overview
Technical Specifications
Core Technology:
- Electric breakdown: ~3000 V per mm
- Optimal distance: 0.5mm from tissue
- Probe tip width: 0.5mm
- Mechanism: Sublimation (solid to gas) without heat transfer
Hardware:
- Three wireless handpieces: White, Green, Red (calibrated for different power levels)
- White handpiece (ophthalmology): 0.7-watt power
- Touch display with multilingual software
- Wireless charging base
- Operating duration: up to 8 hours
Mechanism of Action:
- Generates Reactive Oxygen and Nitrogen Species (RONS)
- Stimulates Type III collagen regeneration
- Causes controlled tissue contraction
- No return electrode needed (unlike electrosurgery)
- Lower power than electrosurgical units
Regulatory Status:
- FDA cleared: skin lesion removal and tissue coagulation
- CE certified (Europe)
- TGA listed (Australia)
- Health Canada licensed (first fully licensed plasma technology, 2021)
- Distributed in 60+ countries
Clinical Evidence:
- 40+ scientific publications
- 12+ years clinical use
- Millions of treatments performed worldwide
Ophthalmological Applications
PANIS Method
Plasma-Assisted Noninvasive Surgery - developed by Iranian Vision Research Center for ocular surface disorders using Plexr Plus technology.
Treatable Pathologies
1. Dermatochalasis (Non-Surgical Blepharoplasty)
- Pathology: Drooping eyelid skin, age-related laxity
- Plexr Plus Results: 100% improvement rate, +2.6 grade increase, immediate visible results lasting years, 30-35% improvement per session
2. Conjunctivochalasis
- Pathology: Loose redundant conjunctiva causing tearing, irritation
- Plexr Plus Results: Grade 3-4 reduced to grade 1-2 in 1 month, all normalized at 6 months, no recurrence, 5-10 minute procedure
3. Pterygium
- Pathology: Fibrovascular growth onto cornea from UV exposure
- Plexr Plus Results: Improved visual acuity, no sutures/glue needed, few minutes procedure (vs. 30 min traditional), 0-33% recurrence rates
4. Conjunctival Nevus
- Pathology: Benign melanocytic tumor
- Plexr Plus Results: Complete disappearance outside limbus, size reduced from 3.89×11.7mm to 0.54×1.69mm, no recurrence, no complications
5. Dry Eye (Punctal Occlusion)
- Pathology: Aqueous deficient dry eye
- Plexr Plus Results: TMH +79.8%, TBUT +69.99%, Schirmer +86.20%, sustained 3-6 months, no foreign body sensation vs. plugs
6. Conjunctival Cyst
- Pathology: Fluid-filled epithelial inclusion cysts
- Plexr Plus Results: 100% complete healing, no recurrence, no complications, no scarring
7. Chalazion
- Pathology: Meibomian gland obstruction/inflammation
- Plexr Plus Application: Alternative to incision/curettage for chronic cases, minimally invasive drainage
8. Entropion
- Pathology: Inward turning eyelid causing corneal irritation
- Plexr Plus Application: Tissue tightening for mild involutional cases, adjunct to correct malposition
9. Conjunctival Stria
- Pathology: Linear conjunctival folds from laxity
- Plexr Plus Application: Tissue shrinkage and remodeling to reduce striations
Key Advantages of Plexr Plus
vs. Surgery:
- No operating room, no general anesthesia, no incisions
- Office-based procedures
- 1-2 day recovery vs. weeks
- Lower cost
vs. Other Energy Devices:
- No heat conduction to surrounding tissue
- More precise (0.5mm tip)
- Safer for periocular/ocular surface
- No return electrode
Clinical Benefits:
- Single device, multiple applications
- Topical anesthesia only
- 5-30 minute procedures
- Immediate results
- Minimal complications
Safety Profile:
- Superficial action preserves deep structures
- No thermal damage to underlying tissue
- Minimal bleeding/inflammation
- 7-14 day healing
Summary
Plexr Plus treats 9 ophthalmological pathologies:
- 2 eyelid disorders
- 5 conjunctival surface disorders
- 2 functional/glandular disorders
Device uniqueness: Wireless handpieces, 0.7W white handpiece for ophthalmology, precise 0.5mm tip, no heat spread, extensive global validation (40+ publications, 60+ countries, 12+ years use).
Visreed